PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome.
Martina SolliniLuca di TommasoMargarita KirienkoChiara PiomboMarco ErreniAndrea Gerardo LaniaPaola Anna ErbaLidija AntunovicArturo ChitiPublished in: EJNMMI research (2019)
PSMA, a marker of neovasculature formation expressed by DTC, contributes in the prediction of tumor aggressiveness and patient outcome.